CN1322821C - 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 - Google Patents
一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 Download PDFInfo
- Publication number
- CN1322821C CN1322821C CNB200510017008XA CN200510017008A CN1322821C CN 1322821 C CN1322821 C CN 1322821C CN B200510017008X A CNB200510017008X A CN B200510017008XA CN 200510017008 A CN200510017008 A CN 200510017008A CN 1322821 C CN1322821 C CN 1322821C
- Authority
- CN
- China
- Prior art keywords
- natto
- powder
- natto powder
- temperature
- hour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000013557 nattō Nutrition 0.000 title claims abstract description 111
- 239000000843 powder Substances 0.000 title claims abstract description 74
- 235000013402 health food Nutrition 0.000 title claims description 28
- 238000000034 method Methods 0.000 title abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 244000068988 Glycine max Species 0.000 claims abstract description 14
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000002775 capsule Substances 0.000 claims description 37
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 30
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 30
- 244000063299 Bacillus subtilis Species 0.000 claims description 23
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 21
- 241001116389 Aloe Species 0.000 claims description 15
- 235000011399 aloe vera Nutrition 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 14
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 12
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 12
- 235000008696 isoflavones Nutrition 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 238000005057 refrigeration Methods 0.000 claims description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 6
- 229960002401 calcium lactate Drugs 0.000 claims description 6
- 239000001527 calcium lactate Substances 0.000 claims description 6
- 235000011086 calcium lactate Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 5
- 229930003944 flavone Natural products 0.000 claims description 5
- 150000002212 flavone derivatives Chemical class 0.000 claims description 5
- 235000011949 flavones Nutrition 0.000 claims description 5
- 229940029982 garlic powder Drugs 0.000 claims description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 abstract description 26
- 241000894006 Bacteria Species 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 9
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 16
- 230000037396 body weight Effects 0.000 description 16
- 229960005069 calcium Drugs 0.000 description 16
- 229910052791 calcium Inorganic materials 0.000 description 16
- 239000011575 calcium Substances 0.000 description 16
- 210000002966 serum Anatomy 0.000 description 16
- 150000003626 triacylglycerols Chemical class 0.000 description 16
- 239000003814 drug Substances 0.000 description 15
- 241000700159 Rattus Species 0.000 description 13
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 108010023302 HDL Cholesterol Proteins 0.000 description 9
- 208000001132 Osteoporosis Diseases 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 9
- 230000002265 prevention Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 235000013339 cereals Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000002504 physiological saline solution Substances 0.000 description 8
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 7
- 229940011871 estrogen Drugs 0.000 description 7
- 239000000262 estrogen Substances 0.000 description 7
- 238000011049 filling Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241001092040 Crataegus Species 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000002537 thrombolytic effect Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 108010048734 sclerotin Proteins 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 230000001833 anti-estrogenic effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000001809 melena Anatomy 0.000 description 3
- 229940086319 nattokinase Drugs 0.000 description 3
- 108010073682 nattokinase Proteins 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 229920002643 polyglutamic acid Polymers 0.000 description 3
- 238000002601 radiography Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 235000015041 whisky Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241001327634 Agaricus blazei Species 0.000 description 2
- 101800004637 Communis Proteins 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- GJAWHXHKYYXBSV-UHFFFAOYSA-N pyridinedicarboxylic acid Natural products OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 2
- 108700022737 rat Fat1 Proteins 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 101100005765 Arabidopsis thaliana CDF1 gene Proteins 0.000 description 1
- 101100007579 Arabidopsis thaliana CPP1 gene Proteins 0.000 description 1
- -1 Ca2+ ion Chemical group 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 101100037618 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ant-1 gene Proteins 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000000640 hydroxylating effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 药物剂量(mg/kg) | 动物数(只) | 血栓湿重(X±SD)mg/1cm | 血栓湿重(X4±SD)mg/1cm |
生理盐水溶栓胶囊纳豆提取物纳豆提取物 | -3807638 | 6666 | 10.0±4.734.42±2.27*3.33±0.68**5.17±1.37* | 4.80±1.891.92±0.86**1.50±0.55***2.50±0.84* |
剂量(mg/kg) | TC(%) | TG(%) |
1350450225 | 24.424.317.0 | 24.214.613.5 |
组别 | 剂量(g/kg) | 动物数 | 首粒排黑便时间的调和均数(min) | 首粒排黑便时间的倒数(1/h)(x±s) | 6h内排便粒数(x±s) |
水药药药 | 01.0g/kg2.5g/kg5.01/kg | 10101010 | 362.30229.0168.54127.39 | 0.166±0.120.262±0.1060.241±0.1790.462±0.29 | 1.7±1.492.67±1.02.38±2.073.56±1.59 |
摄取威士忌后的时间 | ||||
1小时 | 2小时 | 3小时 | 4小时 | |
对照菌 | 20.0±3.4 | 16.3±3.4 | 9.6±3.4 | 5.54±2.4 |
纳豆菌发酵液 | 15.6±3.9 | 14.2±3.7 | 9.0±3.6 | 5.2±3.2 |
阻断率 | 22.8% | 12.9% | 6.3% | 5.5% |
摄取威士忌后的时间 | ||||
1小时 | 2小时 | 3小时 | 4小时 | |
对照菌 | 25.2±16.7 | 20.2±18.5 | 10.6±6.6 | 6.6±4.7 |
纳豆菌发酵液 | 13.9±9.1 | 12.4±7.4 | 7.0±4.6 | 5.2±4.3 |
阻断率 | 44.8% | 38.9% | 34.0% | 16.7% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510017008XA CN1322821C (zh) | 2005-07-26 | 2005-07-26 | 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510017008XA CN1322821C (zh) | 2005-07-26 | 2005-07-26 | 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1714675A CN1714675A (zh) | 2006-01-04 |
CN1322821C true CN1322821C (zh) | 2007-06-27 |
Family
ID=35821092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510017008XA Expired - Fee Related CN1322821C (zh) | 2005-07-26 | 2005-07-26 | 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1322821C (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100448980C (zh) * | 2006-11-16 | 2009-01-07 | 任宪君 | 纳豆粘菌丝及其制备方法和应用 |
CN101411437B (zh) * | 2007-10-18 | 2012-05-30 | 北京小西保健食品有限公司 | 纳豆制备工艺及含纳豆提取物的保健食品 |
CN101449786B (zh) * | 2007-12-07 | 2012-06-27 | 江苏省无锡江大大学科技园有限公司 | 一种无怪味纳豆食品的制造方法 |
CN101606701B (zh) * | 2009-07-20 | 2012-07-04 | 李雪萍 | 纳豆花粉制剂 |
CN101828751B (zh) * | 2010-03-16 | 2012-03-21 | 天津实发中科百奥工业生物技术有限公司 | 纳豆的干燥方法 |
CN101785546A (zh) * | 2010-03-19 | 2010-07-28 | 许勇男 | 纳豆维烯咀嚼片 |
CN101861908A (zh) * | 2010-05-25 | 2010-10-20 | 曾新义 | 一种纳豆制成的冰制品添加剂及其制备方法 |
CN102342496B (zh) * | 2010-07-27 | 2013-04-17 | 李光敏 | 一种北虫草纳豆制品的制备方法 |
CN102379391B (zh) * | 2010-09-03 | 2013-09-25 | 湖北国力生物技术开发有限公司 | 松花粉葡聚糖纳豆保健食品的制备 |
CN102090598A (zh) * | 2010-09-29 | 2011-06-15 | 天津春发食品配料有限公司 | 纳豆菌在制备香味料的应用 |
CN102450643A (zh) * | 2010-10-23 | 2012-05-16 | 张博 | 一种消栓胶囊的制备方法 |
CN102349963B (zh) * | 2011-10-20 | 2013-05-15 | 新时代健康产业(集团)有限公司 | 一种预防微血栓形成的保健品及其制备方法 |
CN102406115B (zh) * | 2011-10-26 | 2013-07-17 | 江苏江大源生态生物科技有限公司 | 一种防治心脑血管疾病的天然功能食品 |
CN102657331A (zh) * | 2012-05-02 | 2012-09-12 | 金光洙 | 用枯草芽孢杆菌发酵的发酵人参、发酵人参纳豆及其提取物的应用 |
CN103098905A (zh) * | 2012-12-14 | 2013-05-15 | 苏州科谷米业有限公司 | 一种纳豆乳粉的制法 |
CN103263012B (zh) * | 2012-12-31 | 2015-02-11 | 孙丽萍 | 一种药食同源的保健食品及其制备方法 |
CN104799292A (zh) * | 2015-05-11 | 2015-07-29 | 黑龙江省祖研北药科技开发有限责任公司 | 一种润肠通便食品及其制备方法 |
CN105310075A (zh) * | 2015-09-23 | 2016-02-10 | 威海南波湾生物技术有限公司 | 一种辅助降血脂的纳豆红曲保健食品制备方法 |
CN105433039A (zh) * | 2015-10-08 | 2016-03-30 | 珠海市现代农业发展中心 | 一种纳豆复合动物原料的有机甲鱼饲料及其制备方法 |
CN105661335A (zh) * | 2016-02-25 | 2016-06-15 | 贵州秀生堂医药生物有限公司 | 一种纳豆肠溶胶囊功能性食品的制备方法 |
CN106036489A (zh) * | 2016-05-26 | 2016-10-26 | 湖北麦克森生物技术有限公司 | 一种纳豆粉的制备方法 |
CN106418097A (zh) * | 2016-09-22 | 2017-02-22 | 辽宁天润生物技术有限公司 | 一种可溶性纳豆表层发酵物的制备方法 |
CN106722188A (zh) * | 2016-12-02 | 2017-05-31 | 南京御匾国健生物科技有限公司 | 一种纳豆粒的制备方法 |
CN108523001A (zh) * | 2018-01-05 | 2018-09-14 | 辽宁亿通宝生物科技有限公司 | 一种纳豆粉及其生产工艺 |
CN108271985A (zh) * | 2018-01-30 | 2018-07-13 | 郑州轻工业学院 | 一种含有鹰嘴豆纳豆菌粉的固体饮料及其制备方法 |
CN108887579A (zh) * | 2018-08-01 | 2018-11-27 | 天津纳美康食品有限公司 | 一种冻干纳豆粉的生产工艺 |
CN111480758A (zh) * | 2019-01-29 | 2020-08-04 | 金振库 | 一种纳豆蒲黄固体饮料及其制备方法 |
CN113519837A (zh) * | 2021-07-24 | 2021-10-22 | 湖北真福医药有限公司 | 一种可改善酒精中毒的溶栓酶制品及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296784A (zh) * | 2000-11-30 | 2001-05-30 | 王彦 | 纳豆饮料 |
CN1302555A (zh) * | 2001-01-17 | 2001-07-11 | 上海交通大学 | 纳豆保健粉的生产工艺 |
-
2005
- 2005-07-26 CN CNB200510017008XA patent/CN1322821C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296784A (zh) * | 2000-11-30 | 2001-05-30 | 王彦 | 纳豆饮料 |
CN1302555A (zh) * | 2001-01-17 | 2001-07-11 | 上海交通大学 | 纳豆保健粉的生产工艺 |
Non-Patent Citations (3)
Title |
---|
纳豆——一种值得开发的食品 齐海萍 钱和 王璋 张可,食品科技,第1期 2003 * |
纳豆——一种值得开发的食品 齐海萍 钱和 王璋 张可,食品科技,第1期 2003;纳豆一种多功能食品 谢秋玲 郭勇,食品工业科技,第1期 1999 * |
纳豆一种多功能食品 谢秋玲 郭勇,食品工业科技,第1期 1999 * |
Also Published As
Publication number | Publication date |
---|---|
CN1714675A (zh) | 2006-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1322821C (zh) | 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 | |
CN102919836B (zh) | 一种降糖、降压、降脂、通便养颜、减肥、抗疲劳保健品及其生产工艺 | |
CN103099089A (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
CN103037882B (zh) | 包含双和汤或其乳酸菌发酵物的用于预防或治疗骨质疏松症的组合物 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN105995331A (zh) | 一种具有改善肠胃功能的陈皮发酵保健饮料及其制备方法 | |
KR101883154B1 (ko) | 흰찰쌀보리를 이용한 당뇨예방에 도움을 주는 발효식품 제조방법 및 그에 의해 제조된 발효식품 | |
KR20120103918A (ko) | 관절염 치료용 한방 액상 발효 조성물의 제조방법 | |
KR20160117034A (ko) | 정자수 증가와 환경호르몬 예방효과를 갖는 성기능 개선용 조성물 및 그의 제조방법 | |
CN106343567A (zh) | 一种诺丽果口服液及其制备方法 | |
JP7007663B2 (ja) | クロモジ抽出物 | |
KR20190113224A (ko) | 쥐눈이콩 및 황칠나무 추출물을 유효성분으로 함유하는 갱년기 질환 예방 및 치료용 조성물 | |
CN108244654A (zh) | 虫草营养早餐粉 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN111771970A (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
CN111387345A (zh) | 一种复合多糖组合物及其制备方法 | |
KR20070076283A (ko) | 혈전 용해능을 가진 기능성 청국장 음료 | |
CN107347997A (zh) | 一种含高钙养心菜的牛奶及其制备方法 | |
CN107375697B (zh) | 一种具有润肠通便的复方制剂及其制备方法和应用 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN104647881A (zh) | 一种解酒护肝养胃的果汁奶茶及其制备方法 | |
CN111067108A (zh) | 一种玫瑰苦荞多肽口服液及其制备方法 | |
CN101244154B (zh) | 用于优生优育预防出生缺陷并改善记忆的药物组合物 | |
CN106999524B (zh) | 含有人参籽油的用于预防和治疗前列腺肥大的组合物 | |
CN110200284A (zh) | 一种刺嫩芽复合壳聚糖降血压咀嚼片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210915 Address after: 133400 Hexi street, Jilin, Longjing Patentee after: Yanbian University Herbal Immortal Pharmaceutical Co.,Ltd. Address before: 133000 Jin Guangzhu Zhuan, 190-4 Xinxing street, Yanji City, Jilin Province Patentee before: Li Yingji |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 133400 Hexi street, Jilin, Longjing Patentee after: Grass Immortal Pharmaceutical Co.,Ltd. Address before: 133400 Hexi street, Jilin, Longjing Patentee before: Yanbian University Herbal Immortal Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070627 |